secwatch / observer
8-K filed May 7, 2024, 7:59 PM ET CIK 0001444380
earnings confidence high sentiment positive materiality 0.70

Nevro Q1 revenue $101.9M (+5.8%), net loss $35.8M; raises adjusted EBITDA guidance, promotes Christoforou to COO

NEVRO CORP

2024-Q1 EPS reported -$0.70 revenue$101,899,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NEVRO CORP updated its full-year 2024 guidance (raised).

Period
full-year 2024
Guidance
raised
Result
guidance update
Exact text from the filing
reaffirming our revenue guidance of $435 million to $445 million for the full-year 2024
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NEVRO CORP updated its full-year 2024 guidance (raised).

Period
full-year 2024
Guidance
raised
Result
guidance update
Exact text from the filing
raising our adjusted EBITDA guidance to a range of a loss of $5 million to positive $2 million
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NEVRO CORP reported first quarter 2024 results: revenue $101.9 million, net income loss of $35.8 million.

Period
first quarter 2024
Revenue
$101.9 million
Net income
loss of $35.8 million
Result
reported results
Exact text from the filing
Worldwide revenue grew to $101.9 million, an increase of 5.8% as reported and 5.6% on a constant currency basis.
View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR
accession 0000950170-24-054492
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.